IROKO CARDIO LLC has a total of 20 patent applications. Its first patent ever was published in 1996. It filed its patents most often in Argentina, Australia and Chile. Its main competitors in its focus markets pharmaceuticals are DEBREGEAS ET ASSOCIES PHARMA, HERMANN HOLGER LARS and CHENG NANZHENG.
# | Country | Total Patents | |
---|---|---|---|
#1 | Argentina | 1 | |
#2 | Australia | 1 | |
#3 | Chile | 1 | |
#4 | Colombia | 1 | |
#5 | Costa Rica | 1 | |
#6 | Dominican Republic | 1 | |
#7 | Ecuador | 1 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | Hungary | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Morocco | 1 | |
#12 | Mexico | 1 | |
#13 | Malaysia | 1 | |
#14 | Nicaragua | 1 | |
#15 | Peru | 1 | |
#16 | El Salvador | 1 | |
#17 | Tunisia | 1 | |
#18 | Taiwan | 1 | |
#19 | Uruguay | 1 | |
#20 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Valgimigli Marco | 13 |
#2 | Marco Valgimigli | 4 |
#3 | Gelotte Karl M | 2 |
Publication | Filing date | Title |
---|---|---|
TW201249439A | Method for reducing thrombocytopenia and thrombocytopenia-associated mortality | |
EP2355824A2 | Method for reducing thrombocytopenia and thrombocytopenia-associated mortality |